Lv35
250 积分 2026-01-07 加入
Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity
1天前
待确认
Harnessing Surface Hydrophilicity of Inhalable Nanoparticles for Precision Delivery of Glucagon-like Peptide-1 Receptor Agonists or Anti-Asthmatic Therapeutics
9天前
已完结
Charge-based supramolecular peptide nanocomplexes for oral delivery via transporter-driven endocytosis
9天前
已完结
Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage
10天前
已完结
Lesional Macrophage‐Targeted Nanomedicine Regulating Cholesterol Homeostasis for the Treatment of Atherosclerosis
17天前
已完结
Advances in β‐Cyclodextrin‐Driven Self‐Healing Materials: Molecular Design and Multifunctional Applications
26天前
已完结
Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis
27天前
已完结
Cyclodextrins as versatile supramolecular building block in nanoscale drug delivery systems for precise tumor chemotherapy
27天前
已完结
Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery
27天前
已完结
Zwitterionic Biomaterials
29天前
已完结
皖公网安备34019202002308